Fig. 4From: The impact on renal function after long-term use of anticoagulants in atrial fibrillation patients(A) Comparison of baseline and 2-year follow-up estimated glomerular filtration rate (eGFR) among rivaroxaban, apixaban, and edoxaban groups after propensity score matching. (B) Comparison of the change in eGFR between 2-year eGFR and baseline eGFR among rivaroxaban, apixaban, and edoxaban groups after propensity score matchingBack to article page